The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Management of Cutaneous Melanoma
Abstract
Cutaneous melanoma remains a management challenge. This year an estimated 55,000 Americans will receive a diagnosis of cutaneous melanoma, and 7900 will die from the disease. The authors of this review discuss the pathogenesis and management of cutaneous melanoma and provide perspective on treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Systemic treatments for metastatic cutaneous melanoma
Crosby, T. D. L., Fish, R., Coles, B., & Mason, M. D. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001215 · Cited by 121
RetractedMutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
Self-citationKirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,094
Atkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048
Self-citationRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Middleton, M. R., Grob, J. J., Aaronson, N., Fierlbeck, G., Tilgen, W., Seiter, S., Gore, M., Aamdal, S., Cebon, J., Coates, A., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.158 · Cited by 1,272
Gershenwald, J. E., Thompson, W., Mansfield, P. F., Lee, J. E., Colome, M. I., Tseng, C.-H., Lee, J. J., Balch, C. M., Reintgen, D. S., & Ross, M. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.976 · Cited by 1,139
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Kirkwood, J. M., Ibrahim, J. G., Sondak, V. K., Richards, J., Flaherty, L. E., Ernstoff, M. S., Smith, T. J., Rao, U., Steele, M., & Blum, R. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2444 · Cited by 912
Kirkwood, J. M., Ibrahim, J. G., Sosman, J. A., Sondak, V. K., Agarwala, S. S., Ernstoff, M. S., & Rao, U. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2370 · Cited by 898
Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'
Clark, W. H. (1978) · Archives of Dermatology · doi:10.1001/archderm.114.5.732 · Cited by 861
Melanoma and sun exposure: An overview of published studies
Elwood, J. M., & Jopson, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971009)73:2<198::aid-ijc6>3.0.co;2-r · Cited by 791
Thin Stage I Primary Cutaneous Malignant Melanoma
Veronesi, U., Cascinelli, N., Adamus, J., Balch, C., Bandiera, D., Barchuk, A., Bufalino, R., Craig, P., De Marsillac, J., Durand, J. C., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181804 · Cited by 563
Kirkwood, J. M., Manola, J., Ibrahim, J., Sondak, V., Ernstoff, M. S., & Rao, U. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1103-3 · Cited by 552
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Livingston, P. O., Wong, G. Y., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlon, C., Calves, M. J., Helling, F., & Ritter, G. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1036 · Cited by 516
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop, D. T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.894 · Cited by 509
Excision Margins in High-Risk Malignant Melanoma
Thomas, J. M., Newton‐Bishop, J., A’Hern, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030681 · Cited by 504
High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi
GREENE, M. H., CLARK, W. H., TUCKER, M. A., KRAEMER, K. H., ELDER, D. E., & FRASER, M. C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-458 · Cited by 455
Grob, J. J., Dreno, B., de la Salmoniere, P., Delaunay, M., Cupissol, D., Guillot, B., Souteyrand, P., Sassolas, B., Cesarini, J.-P., Lionnet, S., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12445-x · Cited by 433
Balch, C. M., Soong, S.-J., Smith, T., Ross, M. I., Urist, M. M., Karakousis, C. P., Temple, W. J., Mihm, M. C., Barnhill, R. L., Jewell, W. R., et al. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0101-x · Cited by 406
Manola, J., Atkins, M., Ibrahim, J., & Kirkwood, J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3782 · Cited by 374
Self-citationEton, O., Legha, S. S., Bedikian, A. Y., Lee, J. J., Buzaid, A. C., Hodges, C., Ring, S. E., Papadopoulos, N. E., Plager, C., East, M. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.044 · Cited by 370
Tsao, H. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.3.282 · Cited by 333
Self-citationNIH Consensus conference. Diagnosis and treatment of early melanoma
Goldsmith, L. A., Askin, F. B., Chang, A. E., Cohen, C., Dutcher, J. P., Gilgor, R. S., Green, S., Harris, E. L., Havas, S., Robinson, J. K., et al. (1992) · JAMA · doi:10.1001/jama.268.10.1314 · Cited by 315
Self-citationRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Seipp, C. A., Einhorn, J. H., White, D. E., & Steinberg, S. M. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.968 · Cited by 312
Soiffer, R., Hodi, F. S., Haluska, F., Jung, K., Gillessen, S., Singer, S., Tanabe, K., Duda, R., Mentzer, S., Jaklitsch, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.005 · Cited by 305
Keilholz, U., Weber, J., Finke, J. H., Gabrilovich, D. I., Kast, W. M., Disis, M. L., Kirkwood, J. M., Scheibenbogen, C., Schlom, J., Maino, V. C., et al. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200203000-00001 · Cited by 298
Self-citationComplications Associated With Sentinel Lymph Node Biopsy for Melanoma
Wrightson, W. R., Wong, S. L., Edwards, M. J., Chao, C., Reintgen, D. S., Ross, M. I., Noyes, R. D., Viar, V., Cerrito, P. B., McMasters, K. M., et al. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.10.001 · Cited by 293
Bliss, J. M., Ford, D., Swerdlow, A. J., Armstrong, B. K., Cristofolini, M., Elwood, J. M., Green, A., Holly, E. A., Mack, T., Mackie, R. M., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620402 · Cited by 263
Cascinelli, N., Belli, F., MacKie, R. M., Santinami, M., Bufalino, R., & Morabito, A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06068-8 · Cited by 250
Nodal Nevi and Cutaneous Melanomas
Carson, K. F., Wen, D.-R., Li, P.-X., Lana, A. M.-A., Bailly, C., Morton, D. L., & Cochran, A. J. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199607000-00006 · Cited by 233
Sosman, J. A., Unger, J. M., Liu, P.-Y., Flaherty, L. E., Park, M. S., Kempf, R. A., Thompson, J. A., Terasaki, P. I., & Sondak, V. K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.072 · Cited by 205
Cole, B. F., Gelber, R. D., Kirkwood, J. M., Goldhirsch, A., Barylak, E., & Borden, E. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2666 · Cited by 203
Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy
Kirkwood, J. M., Bender, C., Agarwala, S., Tarhini, A., Shipe-Spotloe, J., Smelko, B., Donnelly, S., & Stover, L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.052 · Cited by 200
Keilholz, U., Conradt, C., Legha, S. S., Khayat, D., Scheibenbogen, C., Thatcher, N., Goey, S. H., Gore, M., Dorval, T., Hancock, B., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2921 · Cited by 194
Keilholz, U., Goey, S. H., Punt, C. J., Proebstle, T. M., Salzmann, R., Scheibenbogen, C., Schadendorf, D., Liénard, D., Enk, A., Dummer, R., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2579 · Cited by 193
Cochran, A. J., Morton, D. L., Stern, S., Lana, A. M. A., Essner, R., & Wen, D.-R. (2001) · Modern Pathology · doi:10.1038/modpathol.3880358 · Cited by 165
Is Physician Detection Associated With Thinner Melanomas?
Epstein, D. S. (1999) · JAMA · doi:10.1001/jama.281.7.640 · Cited by 164
Hsueh, E. C., Gupta, R. K., Qi, K., & Morton, D. L. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2913 · Cited by 158
Koh, H. K., Norton, L. A., Geller, A. C., et al. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90274-1 · Cited by 152
Gollob, J., Veenstra, K. G., Parker, R. A., Mier, J. W., McDermott, D. F., Clancy, D., Tutin, L., Koon, H. B., & Atkins, M. B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.119 · Cited by 148
Self-citationPrinciples and Practice of the Biologic Therapy of Cancer
Rosenberg, S. A. (2000) · Cited by 147
Goggins, W. B., & Tsao, H. (2003) · Cancer · doi:10.1002/cncr.11116 · Cited by 140
Self-citationPhase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma
Hwu, W., Krown, S. E., Menell, J. H., Panageas, K. S., Merrell, J., Lamb, L. A., Williams, L. J., Quinn, C. J., Foster, T., Chapman, P. B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.061 · Cited by 140
Atkins, M. B., Gollob, J., Sosman, J. A., McDermott, D. F., Tutin, L., Sorokin, P., Parker, R. A., & Mier, J. W. (2002) · PubMed · Cited by 109
Self-citationDouble-blind trial of a polyvalent, shed-antigen, melanoma vaccine.
Bystryn, J., Zeleniuch‐Jacquotte, A., Oratz, R., Shapiro, R. L., Harris, M. N., & Roses, D. F. (2001) · PubMed · Cited by 102
Sentinel Lymph Node Mapping for Thick (?4-mm) Melanoma: Should We Be Doing It?
Carlson, G. W., Murray, D. R., Hestley, A. C., Staley, C. A., Lyles, R. H., & Cohen, C. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.055 · Cited by 91
Risk of Cutaneous Melanoma in Dysplastic Nevus Syndrome Types A and B
Kraemer, K. H., Tucker, M. A., Tarone, R. E., Elder, D., & Clark, W. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612183152518 · Cited by 89
Hillner, B. E., Kirkwood, J. M., Atkins, M. B., Johnson, E. R., & Smith, T. J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2351 · Cited by 87
Self-citationAgarwala, S. S., & Kirkwood, J. M. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199603000-00015 · Cited by 82
Egger, M. E., Scoggins, C. R., & McMasters, K. M. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07828-4 · Cited by 73
Albert, L. S., Rhodes, A. R., & Sober, A. J. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70010-f · Cited by 71
Self-citationUltraviolet radiation and malignant melanoma
Tsao, H., & Sober, A. J. (1998) · Clinics in Dermatology · doi:10.1016/s0738-081x(97)00191-0 · Cited by 39
Self-citationBergen, M., Chen, R. E., & Gonzalez, R. C. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.377 · Cited by 25
Cited by
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
Sosman, J. A., Kim, K. B., Schuchter, L., Gonzalez, R., Pavlick, A. C., Weber, J. S., McArthur, G. A., Hutson, T. E., Moschos, S. J., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112302 · Cited by 2,156
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
Metadata
- Authors
- Tsao, H., Atkins, M. B., & Sober, A. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-09-02
- Volume
- 351
- Issue
- 10
- Pages
- 998-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1997919830
- Cited by
- 855
- References
- 60
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.